Carfilzomib combination treatment as first-line therapy in multiple myeloma: where do we go from the Carthadex (KTd)-trial update?

被引：3

作者：

Engelhardt, Monika ^{[1
,2
]}

Yong, Kwee ^{[3
]}

Bringhen, Sara ^{[4
]}

Waesch, Ralph ^{[1
,2
]}

机构：

[1] Univ Freiburg, Fac Med, Hematol & Oncol, Freiburg, Germany

[2] CCCF, Freiburg, Germany

[3] UCL, London, England

[4] Univ Turin, UNITO Dipartimento Oncol, Turin, Italy

来源：

HAEMATOLOGICA | 2019年 / 104卷 / 11期

关键词：

DEXAMETHASONE; CYCLOPHOSPHAMIDE; THALIDOMIDE; MANAGEMENT;

D O I：

10.3324/haematol.2019.228684

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

[No abstract available]

引用

页码：2128 / 2131

页数：5

共 30 条

[1] Frailty and the management of hematologic malignancies [J].

Abel, Gregory A. ;

Klepin, Heidi D. .

BLOOD, 2018, 131 (05) :515-524

[2]

[Anonymous], 2018, BLOOD, DOI [DOI 10.1182/BLOOD-2018-99-118334, 10.1182/blood-2018-99-118334]

[3]

[Anonymous], BLOOD S1, DOI DOI 10.1182/BLOOD-2018-99-114956

[4] More convenient proteasome inhibition for improved outcomes [J].

Auner, Holger W. ;

Yong, Kwee L. .

LANCET ONCOLOGY, 2018, 19 (07) :856-858

[5] Prevention, monitoring and treatment of cardiovascular adverse events in myeloma patients receiving carfilzomib A consensus paper by the European Myeloma Network and the Italian Society of Arterial Hypertension [J].

Bringhen, S. ;

Milan, A. ;

D'Agostino, M. ;

Ferri, C. ;

Waesch, R. ;

Gay, F. ;

Larocca, A. ;

Offidani, M. ;

Zweegman, S. ;

Terpos, E. ;

Goldschmidt, H. ;

Cavo, M. ;

Ludwig, H. ;

Driessen, C. ;

Auner, H. W. ;

Caers, J. ;

Gramatzki, M. ;

Dimopoulos, M. A. ;

Boccadoro, M. ;

Einsele, H. ;

Sonneveld, P. ;

Engelhardt, M. .

JOURNAL OF INTERNAL MEDICINE, 2019, 286 (01) :63-74

[6] Phase 1/2 study of weekly carfilzomib, cyclophosphamide, dexamethasone in newly diagnosed transplant-ineligible myeloma [J].

Bringhen, S. ;

D'Agostino, M. ;

De Paoli, L. ;

Montefusco, V. ;

Liberati, A. M. ;

Galieni, P. ;

Grammatico, S. ;

Muccio, V. E. ;

Esma, F. ;

De Angelis, C. ;

Musto, P. ;

Ballanti, S. ;

Offidani, M. ;

Petrucci, M. T. ;

Gaidano, G. ;

Corradini, P. ;

Palumbo, A. ;

Sonneveld, P. ;

Boccadoro, M. .

LEUKEMIA, 2018, 32 (04) :979-985

[7]

Bringhen S, 2019, HAEMATOLOGICA

[8] Cardiovascular adverse events in modern myeloma therapy - Incidence and risks. A review from the European Myeloma Network (EMN) and Italian Society of Arterial Hypertension (SIIA) [J].

Bringhen, Sara ;

Milan, Alberto ;

Ferri, Claudio ;

Waesch, Ralph ;

Gay, Francesca ;

Larocca, Alessandra ;

Salvini, Marco ;

Terpos, Evangelos ;

Goldschmidt, Hartmut ;

Cavo, Michele ;

Petrucci, Maria Teresa ;

Ludwig, Heinz ;

Auner, Holger W. ;

Caers, Jo ;

Gramatzki, Martin ;

Boccadoro, Mario ;

Einsele, Hermann ;

Sonneveld, Pieter ;

Engelhardt, Monika .

HAEMATOLOGICA, 2018, 103 (09) :1422-1432

[9] Carfilzomib, cyclophosphamide, and dexamethasone in patients with newly diagnosed multiple myeloma: a multicenter, phase 2 study [J].

Bringhen, Sara ;

Petrucci, Maria Teresa ;

Larocca, Alessandra ;

Conticello, Concetta ;

Rossi, Davide ;

Magarotto, Valeria ;

Musto, Pellegrino ;

Boccadifuoco, Luana ;

Offidani, Massimo ;

Omede, Paola ;

Gentilini, Fabiana ;

Ciccone, Giovannino ;

Benevolo, Giulia ;

Genuardi, Mariella ;

Montefusco, Vittorio ;

Oliva, Stefania ;

Caravita, Tommaso ;

Tacchetti, Paola ;

Boccadoro, Mario ;

Sonneveld, Pieter ;

Palumbo, Antonio .

BLOOD, 2014, 124 (01) :63-69

[10] Cardiovascular Organ Damage and Blood Pressure Levels Predict Adverse Events in Multiple Myeloma Patients Undergoing Carfilzomib Therapy [J].

Bruno, Giulia ;

Bringhen, Sara ;

Maffei, Ilaria ;

Iannaccone, Andrea ;

Crea, Teresa ;

Ravera, Agnese ;

Astarita, Anna ;

Vallelonga, Fabrizio ;

Salvini, Marco ;

Gay, Francesca ;

Veglio, Franco ;

Milan, Alberto .

CANCERS, 2019, 11 (05)

← 1 2 3 →